• PULS will participate at Biotech Umeå Investment Day 2017, in Stockholm on February 2.

A unique Swedish life science development company

PULS turns life science projects into attractive business opportunities for the life science industry. Each project is based on a well-defined medical need. PULS secures long-term financing and world-class scientific and industrial expertise through joint ownership with innovators. Our track record validates all aspects of our business model – a model that serves both innovators and investors well. Try us!

News from PULS

1 December, 2016

Recipharm and Laccure agree commercial collaboration

Leading contract development and manufacturing organisation (CDMO) Recipharm is entering into a collaboration with Laccure AB for the commercial manufacture and delivery of Laccure® Pessary.

10 November, 2016

Oncorena strengthens its Board

Oncorena Holding AB today announces that the company at an extra shareholder’s meeting decided to strengthen the board following the capitalization earlier this autumn.

Find out more
Do you have an idea?
Do you have the knowledge?
Do you have the experience?

© 2012-2017 P.U.L.S. AB | Kullagatan 8, 252 20 Helsingborg, Sweden | All rights reserved.